Importantly, many breast cancer risk-associated SNPs can affect FOXA1-binding affinity for enhancer sequences and eventually increase or prevent transcriptional activity of ER (Meyer and Carroll, 2012[22]). This evidence concerns the gene FOXA1 and breast cancer.